glp 1 drugs for weight loss oral GLP-1 Pill Delivers Injection-Like Results in Clinical Trials crave less GLP-1 Oral Tablet — Zera

Early trial data showed approximately 13% weight loss at 12 weeks, a pace that projects to potentially 25-30%+ at full treatment duration

Priorities to address this include: (a) patient-centered initiation of GLP-1s, including goals for weight reduction and health

February 6, 2025: Ely Lilly Credits Revenue Increase to Zepbound as More Lawsuits Are Filed by People Harmed by the Drug Zepbounds manufacturer, Ely Lilly, reported a 45% increase in revenue in Q4, and credited Zepbound and Mounjaro sales for this increase

This pattern mirrors what we see with other weight loss medications and may relate to differences in baseline body composition

Many things considered healthy for our bodies may influence endogenous GLP-1 in some way, but this does not mean theyre a replacement for this powerful medication

A phase II RCT of lixisenatide in early PD, which was defined as patients recruited within 2 years of diagnosis, also demonstrated the promising disease-modifying effect of lixisenatide, particularly regarding motor disability